6622 — Zhaoke Ophthalmology Share News
0.000.00%
- HK$1.19bn
- HK$662.62m
- CNY31.97m
China's Zhaoke Ophthalmology H1 revenue rises
Brief: Zhaoke Ophthalmology Says Yuvezzitm Approved By Macau Pharmaceutical Administration Bureau
Brief: Zhaoke Ophthalmology Enters Into Definitive Agreement For Acquisition Of Global Rights To NVK002
Brief: Zhaoke Ophthalmology Says Yuvezzitm Approved For Use At Boao Super Hospital
Brief: Zhaoke Ophthalmology Says Ophth-B Atropine Sulfate Eye Drops Application Accepted For Evaluation By Australia's TGA
Brief: Zhaoke Ophthalmology Approves Share Repurchase Plan Up To Hk$100 Million
Brief: Zhaoke Ophthalmology FY Revenue RMB 32 Million
Brief: Zhaoke Ophthalmology Says Tenpoint Therapeutics Receives FDA Approval For Brimocholtm Pf
Brief: Zhaoke Ophthalmology Partners With AFT For Brimocholtm PF In Singapore
Brief: Zhaoke Ophthalmology says Atropine Sulfate Eye Drops Accepted For Evaluation By Australia's TGA
Brief: Zhaoke Ophthalmology Partners With TSH Biopharm For Taiwan Market
Brief: Zhaoke Ophthalmology Says NMPA Approves IND Application For Pan-90806 Eye Drop
Brief: Zhaoke Ophthalmology Says Ferron Granted Exclusive Rights For Brimocholtm Pf
Brief: Zhaoke Ophthalmology Posts HY Loss Rmb116.6 Million
Brief: Zhaoke Ophthalmology Obtains Registration For Tono-I Device From NMPA
Brief: Zhaoke Ophthalmology Says US FDA Grants Orphan Drug Designation To Zhaoke's Melphalan
Brief: Zhaoke Ophthalmology Says NMPA China Accepts New Drug Application For NVK002 Atropine Sulphate Eye Drops 0.02%
Brief: Zhaoke Ophthalmology Announces NMPA Acceptance Of Biologics License Application For TAB014
Brief: Zhaoke Ophthalmology Announces FDA Clearance Of Ind Application For CsA Ophthalmic Gel